Information about Gq Bio Therapeutics Belgium
My details
*
*
*
No warnings for this company
{{translate('company_activity_bron_' + bron)}}
NACE Description
{{activiteit.code}} {{activiteit.description}}

Gq Bio Therapeutics Belgium (SRL)

Company information
Status
Active
Enterprise number
BE0742.926.265
VAT liability
Yes
Established
05-02-2020
Last balance sheet year
2023
Company size
Medium-sized 2 FTE
Principal activity
Research and experimental development on biotechnology
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Gq Bio Therapeutics Belgium

{{translate("download")}}

Publications in the Belgian Official Journal from Gq Bio Therapeutics Belgium

Date Publication
16-05-2023 Gesellschaftsname
07-02-2020 Rubrik Gruendung (Neue Rechtsperson, Eroeffnung Filiale, Usw) (DE)

Frequently asked questions

What is the VAT number of Gq Bio Therapeutics Belgium?
The VAT number of Gq Bio Therapeutics Belgium is BE0742926265.
When was Gq Bio Therapeutics Belgium founded?
Gq Bio Therapeutics Belgium was founded on 05-02-2020.
What is the address of Gq Bio Therapeutics Belgium?
The current registered office of Gq Bio Therapeutics Belgium is located at Industriestrasse 38, 4700 Eupen.
When was the last time Gq Bio Therapeutics Belgium filed their annual financial statements?
The most recent financial statements of Gq Bio Therapeutics Belgium were filed on 14-06-2024. You can view them here.
How many employees does Gq Bio Therapeutics Belgium have?
There are 2 FTEs working at Gq Bio Therapeutics Belgium according to the staff figures in the most recent financial statements.
What is the annual turnover of Gq Bio Therapeutics Belgium?
At the time of its most recent financial statements, Gq Bio Therapeutics Belgium did not publish any turnover figures. Gq Bio Therapeutics Belgium reported a gross margin of €309,970.81.